Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2009, Article ID 124384, 7 pages
http://dx.doi.org/10.1155/2009/124384
Review Article

Complement Inhibition as a Proposed Neuroprotective Strategy following Cardiac Arrest

Department of Neurological Surgery, Columbia University, 710 W. 168th Street, New York, NY 10032, USA

Received 13 May 2009; Revised 18 October 2009; Accepted 4 November 2009

Academic Editor: Fulvio D'Acquisto

Copyright © 2009 Brad E. Zacharia et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Hillmen, N. S. Young, J. Schubert et al., “The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria,” The New England Journal of Medicine, vol. 355, no. 12, pp. 1233–1243, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. L. Testa, W. J. Van Gaal, R. Bhindi et al., “Pexelizumab in ischemic heart disease: a systematic review and meta-analysis on 15,196 patients,” The Journal of Thoracic and Cardiovascular Surgery, vol. 136, no. 4, pp. 884–893, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. B. W. Bottiger, J. Motsch, V. Braun, E. Martin, and M. Kirschfink, “Marked activation of complement and leukocytes and an increase in the concentrations of soluble endothelial adhesion molecules during cardiopulmonary resuscitation and early reperfusion after cardiac arrest in humans,” Critical Care Medicine, vol. 30, no. 11, pp. 2473–2480, 2002. View at Google Scholar · View at Scopus
  4. A. L. D'Ambrosio, D. J. Pinsky, and E. S. Connolly, “The role of the complement cascade in ischemia/reperfusion injury: implications for neuroprotection,” Molecular Medicine, vol. 7, no. 6, pp. 367–382, 2001. View at Google Scholar · View at Scopus
  5. A. F. Ducruet, B. G. Hassid, W. J. MacK et al., “C3a receptor modulation of granulocyte infiltration after murine focal cerebral ischemia is reperfusion dependent,” Journal of Cerebral Blood Flow and Metabolism, vol. 28, no. 5, pp. 1048–1058, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. J. Mocco, W. J. Mack, A. F. Ducruet et al., “Complement component C3 mediates inflammatory injury following focal cerebral ischemia,” Circulation Research, vol. 99, no. 2, pp. 209–217, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. V. S. Ten, S. A. Sosunov, S. P. Mazer et al., “C1q-deficiency is neuroprotective against hypoxic-ischemic brain injury in neonatal mice,” Stroke, vol. 36, no. 10, pp. 2244–2250, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. U. S. Vasthare, F. C. Barone, H. M. Sarau et al., “Complement depletion improves neurological function in cerebral ischemia,” Brain Research Bulletin, vol. 45, no. 4, pp. 413–419, 1998. View at Publisher · View at Google Scholar · View at Scopus
  9. G. Nichol, E. Thomas, C. W. Callaway et al., “Regional variation in out-of-hospital cardiac arrest incidence and outcome,” Journal of the American Medical Association, vol. 300, no. 12, pp. 1423–1431, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. W. Rosamond, K. Flegal, K. Furie et al., “Heart disease and stroke statistics—2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee,” Circulation, vol. 117, no. 4, pp. e25–e146, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. L. Bergner, M. Bergner, A. P. Hallstrom, M. S. Eisenberg, and L. A. Cobb, “Service factors and health status of survivors of out-of-hospital cardiac arrest,” The American Journal of Emergency Medicine, vol. 1, no. 3, pp. 259–263, 1983. View at Publisher · View at Google Scholar · View at Scopus
  12. R. J. Fairbanks, M. N. Shah, E. B. Lerner, K. Ilangovan, E. C. Pennington, and S. M. Schneider, “Epidemiology and outcomes of out-of-hospital cardiac arrest in Rochester, New York,” Resuscitation, vol. 72, no. 3, pp. 415–424, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. M. T. Froehler and R. G. Geocadin, “Hypothermia for neuroprotection after cardiac arrest: mechanisms, clinical trials and patient care,” Journal of the Neurological Sciences, vol. 261, no. 1-2, pp. 118–126, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. R. G. Geocadin and S. M. Eleff, “Cardiac arrest resuscitation: neurologic prognostication and brain death,” Current Opinion in Critical Care, vol. 14, no. 3, pp. 261–268, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. M. C. Geraghty and M. T. Torbey, “Neuroimaging and serologic markers of neurologic injury after cardiac arrest,” Neurologic Clinics, vol. 24, no. 1, pp. 107–121, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. E. P. Hess, R. L. Campbell, and R. D. White, “Epidemiology, trends, and outcome of out-of-hospital cardiac arrest of non-cardiac origin,” Resuscitation, vol. 72, no. 2, pp. 200–206, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. H. A. Püttgen and R. Geocadin, “Predicting neurological outcome following cardiac arrest,” Journal of the Neurological Sciences, vol. 261, no. 1-2, pp. 108–117, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. H. Rosén, K. Stibrant Sunnerhagen, J. Herlitz, C. Blomstrand, and L. Rosengren, “Serum levels of the brain-derived proteins S-100 and NSE predict long-term outcome after cardiac arrest,” Resuscitation, vol. 49, no. 2, pp. 183–191, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. A. L. Sherman, D. L. Tirschwell, P. J. Micklesen, W. T. Longstreth Jr., and L. R. Robinson, “Somatosensory potentials, CSF creatine kinase BB activity, and awakening after cardiac arrest,” Neurology, vol. 54, no. 4, pp. 889–894, 2000. View at Google Scholar · View at Scopus
  20. W. A. Gray, R. J. Capone, and A. S. Most, “Unsuccessful emergency medical resuscitation—are continued efforts in the emergency department justified?” The New England Journal of Medicine, vol. 325, no. 20, pp. 1393–1398, 1991. View at Google Scholar
  21. M. B. Hamel, R. Phillips, J. Teno et al., “Cost effectiveness of aggressive care for patients with nontraumatic coma,” Critical Care Medicine, vol. 30, no. 6, pp. 1191–1196, 2002. View at Google Scholar
  22. M. S. Eisenberg and T. J. Mengert, “Cardiac resuscitation,” The New England Journal of Medicine, vol. 344, no. 17, pp. 1304–1313, 2001. View at Publisher · View at Google Scholar
  23. W. D. Rosamond, L. E. Chambless, A. R. Folsom et al., “Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994,” The New England Journal of Medicine, vol. 339, no. 13, pp. 861–867, 1998. View at Publisher · View at Google Scholar
  24. J. Herlitz, A. Bång, J. Gunnarsson et al., “Factors associated with survival to hospital discharge among patients hospitalised alive after out of hospital cardiac arrest: change in outcome over 20 years in the community of Göteborg, Sweden,” Heart, vol. 89, no. 1, pp. 25–30, 2003. View at Google Scholar
  25. T. D. Rea, R. M. Pearce, T. E. Raghunathan et al., “Incidence of out-of-hospital cardiac arrest,” American Journal of Cardiology, vol. 93, no. 12, pp. 1455–1460, 2004. View at Publisher · View at Google Scholar · View at PubMed
  26. F. Frandsen, J. R. Nielsen, L. Gram, C. F. Larsen, H. R. I. Jorgensen, and P. T. Hole Haghfelt, “Evaluation of intensified prehospital treatment in out-of-hospital cardiac arrest: survival and cerebral prognosis. The Odense ambulance study,” Cardiology, vol. 79, no. 4, pp. 256–264, 1991. View at Google Scholar
  27. G. Nichol, I. G. Stiell, A. Laupacis, B. Pham, V. J. De Maio, and G. A. Wells, “A cumulative meta-analysis of the effectiveness of defibrillator-capable emergency medical services for victims of out-of-hospital cardiac arrest,” Annals of Emergency Medicine, vol. 34, no. 4, part 1, pp. 517–525, 1999. View at Publisher · View at Google Scholar
  28. J. G. van der Hoeven, J. de Koning, P. K. C. van der Weyden, and A. E. Meinders, “Improved outcome for patients with a cardiac arrest by supervision of the emergency medical services system,” Netherlands Journal of Medicine, vol. 46, no. 3, pp. 123–130, 1995. View at Publisher · View at Google Scholar
  29. M. Holzer, S. A. Bernard, S. Hachimi-Idrissi, R. O. Roine, F. Sterz, and M. Müllner, “Hypothermia for neuroprotection after cardiac arrest: systematic review and individual patient data meta-analysis,” Critical Care Medicine, vol. 33, no. 2, pp. 414–418, 2005. View at Publisher · View at Google Scholar
  30. M. Holzer, F. Sterz, J. M. Darby et al., “Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest,” The New England Journal of Medicine, vol. 346, no. 8, pp. 549–556, 2002. View at Publisher · View at Google Scholar · View at PubMed
  31. S. A. Bernard, T. W. Gray, M. D. Buist et al., “Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia,” The New England Journal of Medicine, vol. 346, no. 8, pp. 557–563, 2002. View at Publisher · View at Google Scholar · View at PubMed
  32. I. Laurent, C. Adrie, C. Vinsonneau et al., “High-volume hemofiltration after out-of-hospital cardiac arrest: a randomized study,” Journal of the American College of Cardiology, vol. 46, no. 3, pp. 432–437, 2005. View at Publisher · View at Google Scholar · View at PubMed
  33. V. A. Negovsky and A. M. Gurvitch, “Post-resuscitation disease—a new nosological entity. Its reality and significance,” Resuscitation, vol. 30, no. 1, pp. 23–27, 1995. View at Publisher · View at Google Scholar
  34. S. Gando, S. Nanzaki, Y. Morimoto, S. Kobayashi, and O. Kemmotsu, “Alterations of soluble L- and P-selectins during cardiac arrest and CPR,” Intensive Care Medicine, vol. 25, no. 6, pp. 588–593, 1999. View at Publisher · View at Google Scholar
  35. S. Gando, S. Nanzaki, Y. Morimoto, S. Kobayashi, and O. Kemmotsu, “Out-of-hospital cardiac arrest increases soluble vascular endothelial adhesion molecules and neutrophil elastase associated with endothelial injury,” Intensive Care Medicine, vol. 26, no. 1, pp. 38–44, 2000. View at Google Scholar
  36. A. Geppert, G. Zorn, G. Delle-Karth et al., “Plasma concentrations of von Willebrand factor and intracellular adhesion molecule-1 for prediction of outcome after successful cardiopulmonary resuscitation,” Critical Care Medicine, vol. 31, no. 3, pp. 805–811, 2003. View at Publisher · View at Google Scholar · View at PubMed
  37. C. Adrie, M. Adib-Conquy, I. Laurent et al., “Successful cardiopulmonary resuscitation after cardiac arrest as a “sepsis-like” syndrome,” Circulation, vol. 106, no. 5, pp. 562–568, 2002. View at Publisher · View at Google Scholar
  38. R. E. Chavez-Cartaya, G. P. DeSola, L. Wright, N. V. Jamieson, and D. J. G. White, “Regulation of the complement cascade by soluble complement receptor type 1: protective effect in experimental liver ischemia and reperfusion,” Transplantation, vol. 59, no. 7, pp. 1047–1052, 1995. View at Google Scholar
  39. K. E. Foreman, M. M. Glovsky, R. L. Warner, S. J. Horvath, and P. A. Ward, “Comparative effect of C3a and C5a on adhesion molecule expression on neutrophils and endothelial cells,” Inflammation, vol. 20, no. 1, pp. 1–9, 1996. View at Publisher · View at Google Scholar
  40. J. Hill, T. F. Lindsay, F. Ortiz, C. G. Yeh, H. B. Hechtman, and F. D. Moore Jr., “Soluble complement receptor type 1 ameliorates the local and remote organ injury after intestinal ischemia-reperfusion in the rat,” The Journal of Immunology, vol. 149, no. 5, pp. 1723–1728, 1992. View at Google Scholar
  41. J. H. Hill and P. A. Ward, “The phlogistic role of C3 leukotactic fragments in myocardial infarcts of rats.,” Journal of Experimental Medicine, vol. 133, no. 4, pp. 885–900, 1971. View at Google Scholar
  42. M. Ikai, M. Itoh, T. Joh, Y. Yokoyama, N. Okada, and H. Okada, “Complement plays an essential role in shock following intestinal ischaemia in rats,” Clinical & Experimental Immunology, vol. 106, no. 1, pp. 156–159, 1996. View at Google Scholar
  43. M. Pemberton, G. L. Anderson, V. Vetvicka, D. E. Justus, and G. D. Ross, “Microvascular effects of complement blockade with soluble recombinant CR1 on ischemia/reperfusion injury of skeletal muscle,” The Journal of Immunology, vol. 150, no. 11, pp. 5104–5113, 1993. View at Google Scholar
  44. M. R. Zamora, R. D. Davis, S. H. Keshavjee et al., “Complement inhibition attenuates human lung transplant reperfusion injury: a multicenter trial,” Chest, vol. 116, supplement 1, p. 46S, 1999. View at Publisher · View at Google Scholar
  45. R. M. Cowell, J. M. Plane, and F. S. Silverstein, “Complement activation contributes to hypoxic-ischemic brain injury in neonatal rats,” Journal of Neuroscience, vol. 23, no. 28, pp. 9459–9468, 2003. View at Google Scholar
  46. W. Vogt, B. Damerau, and B. Luhmann, “Complement activation in human lymph: modulation by the contact activation system and by leukocytes,” International Archives of Allergy and Applied Immunology, vol. 79, no. 4, pp. 423–433, 1986. View at Google Scholar
  47. M. Huber-Lang, J. V. Sarma, F. S. Zetoune et al., “Generation of C5a in the absence of C3: a new complement activation pathway,” Nature Medicine, vol. 12, no. 6, pp. 682–687, 2006. View at Publisher · View at Google Scholar · View at PubMed
  48. R. C. Wiggins, P. C. Giclas, and P. M. Henson, “Chemotactic activity generated from the fifth component of complement by plasma kallikrein of the rabbit,” Journal of Experimental Medicine, vol. 153, no. 6, pp. 1391–1404, 1981. View at Google Scholar
  49. P. Gasque, S. K. Singhrao, J. W. Neal et al., “The receptor for complement anaphylatoxin C3a is expressed by myeloid cells and nonmyeloid cells in inflamed human central nervous system: analysis in multiple sclerosis and bacterial meningitis,” The Journal of Immunology, vol. 160, no. 7, pp. 3543–3554, 1998. View at Google Scholar
  50. H. Kasuya and T. Shimizu, “Activated complement components C3a and C4a in cerebrospinal fluid and plasma following subarachnoid hemorrhage,” Journal of Neurosurgery, vol. 71, no. 5, part 1, pp. 741–746, 1989. View at Google Scholar
  51. W. J. Mack, A. F. Ducruet, Z. L. Hickman et al., “Early plasma complement C3a levels correlate with functional outcome after aneurysmal subarachnoid hemorrhage,” Neurosurgery, vol. 61, no. 2, pp. 255–260, 2007. View at Publisher · View at Google Scholar · View at PubMed
  52. J. Mocco, D. A. Wilson, R. J. Komotar et al., “Alterations in plasma complement levels after human ischemic stroke,” Neurosurgery, vol. 59, no. 1, pp. 28–32, 2006. View at Publisher · View at Google Scholar · View at PubMed
  53. G. Széplaki, R. Szegedi, K. Hirschberg et al., “Strong complement activation after acute ischemic stroke is associated with unfavorable outcomes,” Atherosclerosis, vol. 204, no. 1, pp. 315–320, 2009. View at Publisher · View at Google Scholar · View at PubMed
  54. E. D. Pedersen, U. Waje-Andreassen, C. A. Vedeler, G. Aamodt, and T. E. Mollnes, “Systemic complement activation following human acute ischaemic stroke,” Clinical & Experimental Immunology, vol. 137, no. 1, pp. 117–122, 2004. View at Publisher · View at Google Scholar · View at PubMed
  55. J. Van Beek, M. Bernaudin, E. Petit et al., “Expression of receptors for complement anaphylatoxins C3a and C5a following permanent focal cerebral ischemia in the mouse,” Experimental Neurology, vol. 161, no. 1, pp. 373–382, 2000. View at Publisher · View at Google Scholar · View at PubMed
  56. T. V. Arumugam, S.-C. Tang, J. D. Lathia et al., “Intravenous immunoglobulin (IVIG) protects the brain against experimental stroke by preventing complement-mediated neuronal cell death,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 35, pp. 14104–14109, 2007. View at Publisher · View at Google Scholar · View at PubMed
  57. G. H. Kim, J. Mocco, D. K. Hahn et al., “Protective effect of C5a receptor inhibition after murine reperfused stroke,” Neurosurgery, vol. 63, no. 1, pp. 122–125, 2008. View at Publisher · View at Google Scholar · View at PubMed
  58. E. Figueroa, L. E. Gordon, P. W. Feldhoff, and H. A. Lassiter, “The administration of cobra venom factor reduces post-ischemic cerebral injury in adult and neonatal rats,” Neuroscience Letters, vol. 380, no. 1-2, pp. 48–53, 2005. View at Publisher · View at Google Scholar · View at PubMed
  59. N. Akita, H. Nakase, T. Kaido et al., “Protective effect of C1 esterase inhibitor on reperfusion injury in the rat middle cerebral artery occlusion model,” Neurosurgery, vol. 52, no. 2, pp. 395–401, 2003. View at Google Scholar
  60. M. G. De Simoni, C. Storini, M. Barba et al., “Neuroprotection by complement (C1) inhibitor in mouse transient brain ischemia,” Journal of Cerebral Blood Flow and Metabolism, vol. 23, no. 2, pp. 232–239, 2003. View at Google Scholar
  61. C. Atkinson, H. Zhu, F. Qiao et al., “Complement-dependent P-selectin expression and injury following ischemic stroke,” The Journal of Immunology, vol. 177, no. 10, pp. 7266–7274, 2006. View at Google Scholar
  62. S. J. Schultz, H. Aly, B. M. Hasanen et al., “Complement component 9 activation, consumption, and neuronal deposition in the post-hypoxic-ischemic central nervous system of human newborn infants,” Neuroscience Letters, vol. 378, no. 1, pp. 1–6, 2005. View at Publisher · View at Google Scholar · View at PubMed
  63. M. K.-H. Schäfer, W. J. Schwaeble, C. Post et al., “Complement C1q is dramatically up-regulated in brain microglia in response to transient global cerebral ischemia,” The Journal of Immunology, vol. 164, no. 10, pp. 5446–5452, 2000. View at Google Scholar
  64. P. Safar, W. Behringer, B. W. Böttiger, and F. Sterz, “Cerebral resuscitation potentials for cardiac arrest,” Critical Care Medicine, vol. 30, no. 4, supplement, pp. S140–S144, 2002. View at Google Scholar
  65. M. H. Crawford, F. L. Grover, W. P. Kolb et al., “Complement and neutrophil activation in the pathogenesis of ischemic myocardial injury,” Circulation, vol. 78, no. 6, pp. 1449–1458, 1988. View at Google Scholar
  66. J. W. Homeister, P. Satoh, and B. R. Lucchesi, “Effects of complement activation in the isolated heart: role of the terminal complement components,” Circulation Research, vol. 71, no. 2, pp. 303–319, 1992. View at Google Scholar
  67. J. M. Thurman, D. Ljubanovic, C. L. Edelstein, G. S. Gilkeson, and V. M. Holers, “Lack of a functional alternative complement pathway ameliorates ischemic acute renal failure in mice,” The Journal of Immunology, vol. 170, no. 3, pp. 1517–1523, 2003. View at Google Scholar
  68. J. E. Jordan, M. C. Montalto, and G. L. Stahl, “Inhibition of mannose-binding lectin reduces postischemic myocardial reperfusion injury,” Circulation, vol. 104, no. 12, pp. 1413–1418, 2001. View at Google Scholar
  69. M. L. Hart, M. C. Walsh, and G. L. Stahl, “Initiation of complement activation following oxidative stress. In vitro and in vivo observations,” Molecular Immunology, vol. 41, no. 2-3, pp. 165–171, 2004. View at Publisher · View at Google Scholar · View at PubMed
  70. W. Zhou, C. A. Farrar, K. Abe et al., “Predominant role for C5b-9 in renal ischemia/reperfusion injury,” The Journal of Clinical Investigation, vol. 105, no. 10, pp. 1363–1371, 2000. View at Google Scholar
  71. M. R. Weiser, J. P. Williams, F. D. Moore Jr. et al., “Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement,” Journal of Experimental Medicine, vol. 183, no. 5, pp. 2343–2348, 1996. View at Publisher · View at Google Scholar
  72. J. M. Weiler, R. E. Edens, R. J. Linhardt, and D. P. Kapelanski, “Heparin and modified heparin inhibit complement activation in vivo,” The Journal of Immunology, vol. 148, no. 10, pp. 3210–3215, 1992. View at Google Scholar
  73. W. Gaszynski, “The use of protease inhibitor (trasylol) and heparin in cardiorespiratory resuscitation. I. Studies of the blood clotting system,” Anaesthesia Resuscitation and Intensive Therapy, vol. 3, no. 2, pp. 125–134, 1975. View at Google Scholar
  74. M. Aoki, R. A. Jonas, F. Nomura et al., “Effects of aprotinin on acute recovery of cerebral metabolism in piglets after hypothermic circulatory arrest,” Annals of Thoracic Surgery, vol. 58, no. 1, pp. 146–153, 1994. View at Google Scholar
  75. R. Busto, M. Y.-T. Globus, W. D. Dietrich, E. Martinez, I. Valdes, and M. D. Ginsberg, “Effect of mild hypothermia on ischemia-induced release of neurotransmitters and free fatty acids in rat brain,” Stroke, vol. 20, no. 7, pp. 904–910, 1989. View at Google Scholar
  76. M. A. Yenari and H. S. Han, “Influence of hypothermia on post-ischemic inflammation: role of nuclear factor kappa B (NFκB),” Neurochemistry International, vol. 49, no. 2, pp. 164–169, 2006. View at Publisher · View at Google Scholar · View at PubMed
  77. J. Inamasu, S. Suga, S. Sato et al., “Post-ischemic hypothermia delayed neutrophil accumulation and microglial activation following transient focal ischemia in rats,” Journal of Neuroimmunology, vol. 109, no. 2, pp. 66–74, 2000. View at Publisher · View at Google Scholar
  78. J. Inamasu, S. Suga, S. Sato et al., “Intra-ischemic hypothermia attenuates intercellular adhesion molecule-1 (ICAM-1) and migration of neutrophil,” Neurological Research, vol. 23, no. 1, pp. 105–111, 2001. View at Publisher · View at Google Scholar
  79. C. W. Callaway, J. C. Rittenberger, E. S. Logue, and M. J. McMichael, “Hypothermia after cardiac arrest does not alter serum inflammatory markers,” Critical Care Medicine, vol. 36, no. 9, pp. 2607–2612, 2008. View at Publisher · View at Google Scholar · View at PubMed
  80. A. I. Qureshi, “Serum inflammatory markers after postcardiac arrest resuscitation: surrogate markers of efficacy, therapeutic targets, or innocent bystanders,” Critical Care Medicine, vol. 36, no. 9, pp. 2698–2699, 2008. View at Publisher · View at Google Scholar · View at PubMed
  81. Y. Rahpeymai, M. A. Hietala, U. Wilhelmsson et al., “Complement: a novel factor in basal and ischemia-induced neurogenesis,” EMBO Journal, vol. 25, no. 6, pp. 1364–1374, 2006. View at Publisher · View at Google Scholar · View at PubMed